BRPI0806543A2 - Composições de comprimido em comprimido - Google Patents

Composições de comprimido em comprimido

Info

Publication number: BRPI0806543A2
Authority: BR; Brazil
Prior art keywords: pill; compositions; pill compositions
Prior art date: 2007-01-12

Application number

BRPI0806543-8A2A

Other languages

English (en)

Inventor

Xiuying Liu

John Kresevic

Nizamuddin Baksh

Robin Enever

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-01-12

Filing date

2008-01-11

Publication date

2014-04-22

2008-01-11 Application filed by Wyeth Corp filed Critical Wyeth Corp

2014-04-22 Publication of BRPI0806543A2 publication Critical patent/BRPI0806543A2/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0806543-8A2A 2007-01-12 2008-01-11 Composições de comprimido em comprimido BRPI0806543A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US88480107P	2007-01-12	2007-01-12
PCT/US2008/050899 WO2008089087A2 (en)	2007-01-12	2008-01-11	Tablet-in-tablet compositions

Publications (1)

Publication Number	Publication Date
BRPI0806543A2 true BRPI0806543A2 (pt)	2014-04-22

Family

ID=39315069

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0806543-8A2A BRPI0806543A2 (pt)	2007-01-12	2008-01-11	Composições de comprimido em comprimido

Country Status (16)

Country	Link
US (1)	US20080175908A1 (pt)
EP (1)	EP2117518A2 (pt)
JP (1)	JP2010515758A (pt)
KR (1)	KR20090104862A (pt)
CN (1)	CN101631536A (pt)
AR (1)	AR064875A1 (pt)
AU (1)	AU2008206476A1 (pt)
BR (1)	BRPI0806543A2 (pt)
CL (1)	CL2008000095A1 (pt)
CO (1)	CO6210806A2 (pt)
IL (1)	IL199656A0 (pt)
MX (1)	MX2009007254A (pt)
PE (1)	PE20081632A1 (pt)
RU (1)	RU2009125413A (pt)
TW (1)	TW200836773A (pt)
WO (1)	WO2008089087A2 (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN108421044A (zh)	2005-02-03	2018-08-21	综合医院公司	治疗吉非替尼耐药性癌症的方法
BRPI0618042A2 (pt)	2005-11-04	2011-08-16	Wyeth Corp	usos de uma rapamicina e de uma herceptina, produto, pacote farmacêutico, e, composição farmacêutica
SA07280459B1 (ar)	2006-08-25	2011-07-20	بيورديو فارما إل. بي.	أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
US8022216B2 (en)	2007-10-17	2011-09-20	Wyeth Llc	Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
CN102641270A (zh)	2008-06-17	2012-08-22	惠氏有限责任公司	含有hki-272和长春瑞滨的抗肿瘤组合
WO2009158584A1 (en) *	2008-06-27	2009-12-30	Wyeth	Dual adhesive technology
US8669273B2 (en)	2008-08-04	2014-03-11	Wyeth Llc	Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
IL264349B2 (en)	2009-04-06	2024-01-01	Wyeth Llc	Regimen comprising neratinib for the treatment of cancer
US20110217369A1 (en) *	2009-09-03	2011-09-08	Ranbaxy Laboratories Limited	Fenofibrate compositions
WO2011056532A2 (en)	2009-10-27	2011-05-12	Wyeth Llc	Bazedoxifene formulations with antioxidants
FI4066821T3 (fi)	2009-11-09	2025-05-13	Wyeth Llc	Neratinibimaleaatin tablettiformulaatioita
NZ599762A (en)	2009-11-09	2014-07-25	Wyeth Llc	Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
SG10201407881WA (en) *	2009-11-27	2015-01-29	Genzyme Corp	An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
US20110280936A1 (en) *	2010-05-17	2011-11-17	Aptapharma, Inc.	Self Breaking Tablets
EP2826467B1 (en)	2010-12-22	2017-08-02	Purdue Pharma L.P.	Encased tamper resistant controlled release dosage forms
PH12013501345A1 (en)	2010-12-23	2022-10-24	Purdue Pharma Lp	Tamper resistant solid oral dosage forms
WO2012164096A1 (en)	2011-06-01	2012-12-06	Estetra S.A.	Process for the production of estetrol intermediates
BR112013030833B1 (pt)	2011-06-01	2019-09-03	Estetra S A	processo para a preparação de um composto de fórmula (i) e processo para a preparação de estetrol
EP2383279A1 (en)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Process for the preparation of estetrol
RS62297B1 (sr)	2011-11-23	2021-09-30	Therapeuticsmd Inc	Prirodne kombinovane hormonske supstitucione formulacije i terapije
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
CN104487094B (zh)	2012-07-20	2017-05-17	大塚制药株式会社	表面具有干燥油墨被膜的片剂、及用于喷墨打印机的油墨
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10751287B2 (en)	2013-03-15	2020-08-25	Purdue Pharma L.P.	Tamper resistant pharmaceutical formulations
HUE035848T2 (en) *	2013-12-12	2018-05-28	Donesta Bioscience B V	Solid dispensing unit containing an estetrol compound in the mouth
RU2016143081A (ru)	2014-05-22	2018-06-26	Терапьютиксмд, Инк.	Натуральные комбинированные гормонозаместительные составы и терапии
CN104013630B (zh) *	2014-05-23	2018-08-21	合肥九研医药科技开发有限公司	一种复方醋酸巴多昔芬雌激素组合物
EP3174542A4 (en)	2014-07-29	2018-01-03	TherapeuticsMD, Inc.	Transdermal cream
CN104546794A (zh) *	2015-01-05	2015-04-29	万特制药(海南)有限公司	一种醋酸巴多昔芬胶囊及其制备方法
LT3310345T (lt)	2015-06-18	2021-06-25	Estetra Sprl	Burnoje disperguojama tabletė, turinti estetrolio
RS57328B1 (sr)	2015-06-18	2018-08-31	Mithra Pharmaceuticals S A	Orodisperzibilna dozna jedinica koja sadrži estetrolsku komponentu
WO2016203044A1 (en)	2015-06-18	2016-12-22	Mithra Pharmaceuticals S.A.	Orodispersible tablet containing estetrol
NZ737945A (en)	2015-06-18	2023-06-30	Estetra Sprl	Orodispersible dosage unit containing an estetrol component
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
US9931349B2 (en)	2016-04-01	2018-04-03	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
KR101893110B1 (ko) *	2016-07-27	2018-08-31	삼일제약 주식회사	비페닐디메틸디카르복실레이트 및 마늘유를 포함하는 제제
CA3178291A1 (en)	2016-08-05	2018-04-12	Estetra Srl	Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	化合物及其用於緩解絕經相關症狀的用途
CR20200486A (es)	2018-04-19	2021-01-27	Estetra Sprl	Compuestos y sus usos para aliviar los síntomas asociados a la menopausa
CN111067907A (zh) *	2018-10-18	2020-04-28	常州大学	孕激素在抑制血管内皮生长因子表达中的应用
KR102372271B1 (ko) *	2020-01-03	2022-03-10	주식회사 서흥	천연 소재에 기반한 정제 조성물 및 정제
TWI893101B (zh)	2020-04-16	2025-08-11	比利時商埃斯特拉有限責任公司	具有降低之副作用之避孕組成物
CN115989023A (zh) *	2020-08-25	2023-04-18	艾伯维公司	多药物递送的系统和方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2565115A (en) *	1948-10-28	1951-08-21	Squibb & Sons Inc	Method of obtaining a conjugated estrogen preparation
US2720483A (en) *	1951-02-21	1955-10-11	Olin Mathieson	Method of obtaining a conjugatedestrogen preparation
US5210081A (en) *	1992-02-26	1993-05-11	American Home Products Corporation	Alkali metal 8,9-dehydroestrone sulfate esters
US5554601A (en) *	1993-11-05	1996-09-10	University Of Florida	Methods for neuroprotection
US5998402A (en) *	1996-04-19	1999-12-07	American Home Products Corporation	2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US6372254B1 (en) *	1998-04-02	2002-04-16	Impax Pharmaceuticals Inc.	Press coated, pulsatile drug delivery system suitable for oral administration
US6479535B1 (en) *	1998-05-15	2002-11-12	Wyeth	2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
EP1753407B1 (en) *	2004-06-07	2017-03-08	Wyeth LLC	Sugar coatings and methods therefor
KR20080031037A (ko) *	2005-06-29	2008-04-07	와이어쓰	결합형 에스트로겐과 바제독시펜의 제형
CN101541326A (zh) *	2006-11-29	2009-09-23	惠氏公司	雌激素/选择性雌激素受体调节剂（serm）和雌激素/孕酮双层药片

2008
- 2008-01-11 KR KR1020097016863A patent/KR20090104862A/ko not_active Withdrawn
- 2008-01-11 MX MX2009007254A patent/MX2009007254A/es not_active Application Discontinuation
- 2008-01-11 WO PCT/US2008/050899 patent/WO2008089087A2/en not_active Ceased
- 2008-01-11 US US12/013,109 patent/US20080175908A1/en not_active Abandoned
- 2008-01-11 JP JP2009545710A patent/JP2010515758A/ja active Pending
- 2008-01-11 CL CL200800095A patent/CL2008000095A1/es unknown
- 2008-01-11 EP EP08727602A patent/EP2117518A2/en not_active Withdrawn
- 2008-01-11 TW TW097101166A patent/TW200836773A/zh unknown
- 2008-01-11 CN CN200880007862A patent/CN101631536A/zh active Pending
- 2008-01-11 AU AU2008206476A patent/AU2008206476A1/en not_active Abandoned
- 2008-01-11 RU RU2009125413/15A patent/RU2009125413A/ru not_active Application Discontinuation
- 2008-01-11 PE PE2008000126A patent/PE20081632A1/es not_active Application Discontinuation
- 2008-01-11 BR BRPI0806543-8A2A patent/BRPI0806543A2/pt not_active IP Right Cessation
- 2008-01-11 AR ARP080100140A patent/AR064875A1/es unknown
2009
- 2009-07-02 IL IL199656A patent/IL199656A0/en unknown
- 2009-07-08 CO CO09070672A patent/CO6210806A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR064875A1 (es)	2009-04-29
TW200836773A (en)	2008-09-16
KR20090104862A (ko)	2009-10-06
CO6210806A2 (es)	2010-10-20
JP2010515758A (ja)	2010-05-13
CL2008000095A1 (es)	2008-05-16
MX2009007254A (es)	2009-08-12
PE20081632A1 (es)	2008-12-10
IL199656A0 (en)	2010-04-15
CN101631536A (zh)	2010-01-20
US20080175908A1 (en)	2008-07-24
EP2117518A2 (en)	2009-11-18
WO2008089087A2 (en)	2008-07-24
AU2008206476A1 (en)	2008-07-24
RU2009125413A (ru)	2011-02-20
WO2008089087A3 (en)	2009-06-25

Legal Events

Date	Code	Title	Description
2014-08-26	B08L	Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]	Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 4A, 5A E 6A ANUIDADES.
2020-11-10	B08I	Publication cancelled [chapter 8.9 patent gazette]	Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.
2020-11-17	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 4A, 5A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES.
2021-03-09	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
LTPA2018005I1 (lt)	2018-02-12	Farmacinė kompozicija
BRPI0810634A2 (pt)	2014-10-07	Composições fungicidas
HUE059171T2 (hu)	2022-10-28	Kompozíciók
DK2209856T3 (da)	2019-10-21	Aerogelsammensætninger
RU2493831C3 (ru)	2017-06-08	Фармацевтические композиции
EP2167043A4 (en)	2013-05-01	NEW USE CO-CRYSTAL COMPOSITIONS
DK2634232T3 (da)	2022-06-07	Sammensætninger
DK2395834T3 (da)	2019-09-02	Natriumnitrit-holdige farmaceutiske sammensætninger
BRPI0813775A2 (pt)	2015-01-06	Composição
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
EP2381760A4 (en)	2013-01-16	CORN PROTEIN COMPOSITION
ATE528048T1 (de)	2011-10-15	Schweisshemmende/desodorierende zusammensetzung
DK2966175T3 (da)	2019-07-01	Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
IL199656A0 (en)	2010-04-15	Tablet-in-tablet compositions
BRPI0718428A2 (pt)	2013-11-12	Composição de ibuprofeno
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
BRPI0810557A2 (pt)	2016-07-19	composição
BRPI0811274A2 (pt)	2014-10-07	Composição
EP2197828A4 (en)	2011-09-21	FULLEREN-MULTIADDUKT COMPOSITION
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
PT2182988E (pt)	2014-05-16	Composição radiofarmacêutica
BRPI0718141A2 (pt)	2013-11-05	Composições de frangrâncias
BRPI0820198A2 (pt)	2019-09-24	composições farmacêuticas
BRPI0811002A2 (pt)	2015-01-27	Composição biofertilizante
DK2170292T3 (da)	2014-04-07	Atazanavirholdige sammensætninger i tabletform